Pune, India -- (SBWIRE) -- 04/16/2019 -- Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The latest Nuclear Medicine Market research report added by Garner Insights comprises thorough market perspectives outlining upcoming view of the market. The Nuclear Medicine Market report analyses important aspects that assists the industry professionals, business analyst, and the decision makers accordingly to plan out the business policies and achievement anticipated over the business objectives.
Avail a Sample Report @ http://bit.ly/2XcWrZh
The Nuclear Medicine Market report is equipped with plenty of graphical representations for a smooth understanding of the data which is presented in a chapter-wise format. The outlining of key market Segments also helps in defining the state and direction of the industry.
Moreover, the study supports venture capitalists in getting to know the companies better and carry out informed decision making. The Nuclear Medicine Manufacturing industry is rapidly becoming dynamic and innovative, with a significant number of private players coming into the industry.
Leading players operating in the market:
GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma, Eli Lilly, SIEMENS, China Isotope & Radiation, Dongcheng, .
Global Nuclear Medicine (K Units) and Revenue (Million USD) Market Split by Product Type:
Tc-Diagnostic, Therapeutic, I-123/131, In-111, Xe-133, Th-201, Ga-67, Other.
Global Nuclear Medicine (K Units) by Application (2019-2024):
Geographically, this report is segmented into various key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Nuclear Medicine in the mentioned regions, from 2012 to 2024 (forecast), covering North America (USA, Canada and Mexico), South America (Brazil, Argentina, Columbia etc.), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), Europe (Germany, France, UK, Russia and Italy), and Middle East and Africa (UAE, Saudi Arabia, Egypt, Nigeria and South Africa).
Check Discount Link: http://bit.ly/2XjqZst
The Chapters talked about in the global Nuclear Medicine market.
Chapter 1, to describe Nuclear Medicine Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to examine the leading manufacturers of Nuclear Medicine, with sales, revenue, and price of Nuclear Medicine, in 2017 and 2019;
Chapter 3, to disclose the competitive scenario among the top manufacturers, with sales, revenue, and market share in 2016 and 2017;
Chapter 4, to demonstrate the global market by regions, with sales, revenue and market share of Nuclear Medicine, for each region, from 2012 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by regions, by type, by application, and by manufacturers, with revenue, sales, and market share by key countries in these regions.
Access full report @ http://bit.ly/2XjygZp
The Nuclear Medicine Market report provides the principle locale, economic situations with the item value, benefit, limit, generation, supply, request and market development rate and figure and more. The report alongside offer new task SWOT examination, speculation attainability investigation, and venture return investigation.
About Garner Insights
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.
Mr. Kevin Thomas
+1 513 549 5911 (US)
+44 203 318 2846 (UK)